Bloomberg @business
Zantac was taken off the shelves in 2020 over links to cancer. A Businessweek investigation has uncovered hundreds of documents that show how the drug’s maker kept quiet about those risks for 40 years Read The Big Take ⬇️ https://t.co/bjDKyeLxIG via @BW — PolitiTweet.org